Pullen Investment Management LLC Has $2.06 Million Stock Holdings in Kenvue Inc. (NYSE:KVUE)

Pullen Investment Management LLC grew its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 22.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 85,894 shares of the company's stock after purchasing an additional 15,987 shares during the quarter. Kenvue makes up approximately 1.3% of Pullen Investment Management LLC's investment portfolio, making the stock its 23rd largest holding. Pullen Investment Management LLC's holdings in Kenvue were worth $2,060,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Handelsbanken Fonder AB raised its holdings in Kenvue by 2.9% in the 4th quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company's stock valued at $15,846,000 after acquiring an additional 21,222 shares during the period. Alberta Investment Management Corp grew its position in shares of Kenvue by 23.2% in the fourth quarter. Alberta Investment Management Corp now owns 582,895 shares of the company's stock valued at $12,445,000 after purchasing an additional 109,700 shares during the last quarter. Longbow Finance SA grew its position in shares of Kenvue by 5.0% in the fourth quarter. Longbow Finance SA now owns 280,568 shares of the company's stock valued at $5,990,000 after purchasing an additional 13,287 shares during the last quarter. Steward Partners Investment Advisory LLC increased its stake in shares of Kenvue by 143.1% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company's stock worth $1,023,000 after purchasing an additional 28,216 shares during the period. Finally, CORDA Investment Management LLC. lifted its holdings in Kenvue by 1.4% during the 4th quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company's stock worth $26,754,000 after purchasing an additional 17,466 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analyst Ratings Changes

A number of research analysts have commented on KVUE shares. Evercore ISI started coverage on Kenvue in a report on Monday, March 24th. They issued an "in-line" rating and a $25.00 price objective on the stock. Redburn Atlantic started coverage on shares of Kenvue in a research note on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price target on the stock. Canaccord Genuity Group lifted their price objective on shares of Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a research note on Wednesday, March 5th. Citigroup boosted their price objective on shares of Kenvue from $22.00 to $24.50 and gave the company a "neutral" rating in a report on Friday, May 9th. Finally, Piper Sandler increased their target price on shares of Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a research report on Monday, February 24th. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $25.33.

Kenvue Price Performance

Shares of NYSE:KVUE traded down $0.60 during midday trading on Friday, hitting $21.44. The stock had a trading volume of 37,242,399 shares, compared to its average volume of 16,485,332. The company's 50-day moving average price is $23.03 and its 200-day moving average price is $22.50. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $25.17. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $41.14 billion, a P/E ratio of 40.46, a price-to-earnings-growth ratio of 2.62 and a beta of 0.98.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.01. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The business had revenue of $3.74 billion for the quarter, compared to analysts' expectations of $3.69 billion. During the same period last year, the firm posted $0.28 earnings per share. The firm's quarterly revenue was down 3.9% compared to the same quarter last year. As a group, equities research analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th were issued a dividend of $0.205 per share. The ex-dividend date of this dividend was Wednesday, May 14th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.82%. Kenvue's dividend payout ratio (DPR) is currently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.